Actos

Main information

  • Trade name:
  • Actos 45 mg Tablet
  • Dosage:
  • 45 mg
  • Pharmaceutical form:
  • Tablet
  • Units in package:
  • Blister pack, Al-Al; 28 tabs, 28 tablets
  • Class:
  • Prescription
  • Prescription type:
  • Prescription
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug
  • Manufactured by:
  • Juzen Chemical Corporation

Documents

Localization

  • Available in:
  • Actos 45 mg Tablet
    New Zealand
  • Language:
  • English

Other information

Status

  • Source:
  • Medsafe - Medicines Safety Authority - New Zealand
  • Authorization number:
  • 9437
  • Authorization date:
  • 28-10-1999
  • Last update:
  • 27-09-2017

30-11-2018

Pioglitazone Teva (Teva B.V.)

Pioglitazone Teva (Teva B.V.)

Pioglitazone Teva (Active substance: pioglitazone) - Centralised - Yearly update - Commission Decision (2018)8159 of Fri, 30 Nov 2018

Europe -DG Health and Food Safety

30-11-2018

Pioglitazone Teva Pharma (Teva B.V.)

Pioglitazone Teva Pharma (Teva B.V.)

Pioglitazone Teva Pharma (Active substance: pioglitazone) - Centralised - Yearly update - Commission Decision (2018)8158 of Fri, 30 Nov 2018

Europe -DG Health and Food Safety

28-5-2018

Incresync (Takeda Pharma A/S)

Incresync (Takeda Pharma A/S)

Incresync (Active substance: alogliptin / pioglitazone) - Centralised - Renewal - Commission Decision (2018)3347 of Mon, 28 May 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/2178/R/23

Europe -DG Health and Food Safety